A Study to Investigate the Safety and Tolerability of Single and Multiple Ascending Doses of KIT2014 in Healthy Subjects

Clinical trial NCT06659757 · COMPLETED

Trial details

NCT number: NCT06659757
Sponsor: Kither Biotech Srl
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2024-10-16
Primary completion: 2025-07-14
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.